Jun Zhang - Researcher Profile | RDL Research Database

Publications

2 shown

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial

Fengcai Zhu , Xu-Hua Guan , Yu-Hua Li +26 more

2020 The Lancet 1278 citations

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

Xiangyang Chi , Renhong Yan , Jun Zhang +21 more

Hitting SARS-CoV-2 in a new spot A key target for therapeutic antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the spike protein, a trimeric pr...

2020 Science 1543 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 2,821
Institution: Academy of Military Medical Sciences

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-9650-112X

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.